Larimar Therapeutics, Inc. (LRMR) KPIs and segments

LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 5/30

$2.70−0.03 (-1.10%)

Close on Nov 12, 2026Market cap $280.48MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Larimar Therapeutics's business

Coming soon

This tab will track the numbers specific to Larimar Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?